story of the week
Pertuzumab and Trastuzumab With or Without Metronomic Chemotherapy for Older Patients With HER2-Positive Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pertuzumab and Trastuzumab With or Without Metronomic Chemotherapy for Older Patients With HER2-Positive Metastatic Breast Cancer (EORTC 75111-10114): An Open-Label, Randomised, Phase 2 Trial From the Elderly Task Force/Breast Cancer Group
Lancet Oncol 2018 Feb 09;[EPub Ahead of Print], H Wildiers, K Tryfonidis, L Dal Lago, P Vuylsteke, G Curigliano, S Waters, B Brouwers, S Altintas, N Touati, F Cardoso, E BrainFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.